Hiroyuki Hasegawa
Director/Board Member at Kamui Pharma, Inc.
Hiroyuki Hasegawa active positions
| Companies | Position | Start | End |
|---|---|---|---|
Mitsubishi UFJ Capital Co., Ltd.
 Mitsubishi UFJ Capital Co., Ltd. Investment ManagersFinance Mitsubishi UFJ Capital Co., Ltd. (MUCAP) is a venture capital subsidiary of Mitsubishi UFJ Financial Group, Inc. (TSE: 8306; NYSE: MTU), founded in 1974. The firm is headquartered in Tokyo with additional offices in Nagoya and Osaka. | Private Equity Investor | 01/01/2004 | - |
Kamui Pharma, Inc.
 Kamui Pharma, Inc. Pharmaceuticals: MajorHealth Technology Kamui Pharma, Inc. is a pharmaceutical company based in Japan. The company's description is in Japanese, but it appears to focus on research and development in the pharmaceutical industry. The company was founded in 2018 by Naoki Ogawa, who has been the CEO since then. | Director/Board Member | - | - |
Career history of Hiroyuki Hasegawa
Former positions of Hiroyuki Hasegawa
| Companies | Position | Start | End |
|---|---|---|---|
| CHORDIA THERAPEUTICS INC. | Director/Board Member | - | - |
| VERITAS IN SILICO INC. | Director/Board Member | - | - |
Statistics
International
| Japan | 5 |
Operational
| Director/Board Member | 3 |
| Private Equity Investor | 1 |
Sectoral
| Health Technology | 4 |
| Finance | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 2 |
|---|---|
| VERITAS IN SILICO INC. | Health Technology |
| CHORDIA THERAPEUTICS INC. | Health Technology |
| Private companies | 2 |
|---|---|
Mitsubishi UFJ Capital Co., Ltd.
Mitsubishi UFJ Capital Co., Ltd. Investment ManagersFinance Mitsubishi UFJ Capital Co., Ltd. (MUCAP) is a venture capital subsidiary of Mitsubishi UFJ Financial Group, Inc. (TSE: 8306; NYSE: MTU), founded in 1974. The firm is headquartered in Tokyo with additional offices in Nagoya and Osaka. | Finance |
Kamui Pharma, Inc.
Kamui Pharma, Inc. Pharmaceuticals: MajorHealth Technology Kamui Pharma, Inc. is a pharmaceutical company based in Japan. The company's description is in Japanese, but it appears to focus on research and development in the pharmaceutical industry. The company was founded in 2018 by Naoki Ogawa, who has been the CEO since then. | Health Technology |
- Stock Market
- Insiders
- Hiroyuki Hasegawa
- Experience
